Literature DB >> 3111749

Concentrations of iodothyronines in serum of patients with chronic renal failure and other nonthyroidal illnesses: role of free fatty acids.

K Liewendahl, S Tikanoja, H Mähönen, T Helenius, M Välimäki, L G Tallgren.   

Abstract

The mean concentration of free thyroxin (FT4) in serum, as determined by direct equilibrium dialysis, was decreased in patients with chronic renal failure (CRF) and increased in patients with various other nonthyroidal illnesses (NTI). The mean concentration of dialyzable free triiodothyronine (FT3) in serum was equally low in both groups of patients. Patients with CRF of various etiology but a similar degree of renal failure as estimated from serum creatinine assay had very similar concentrations of FT4 and FT3 in their serum. Mean thyroxin (T4) and triiodothyronine (T3) concentrations in serum were decreased in CRF and NTI, whereas the mean reverse-T3 concentration in serum was normal in CRF and increased in NTI. T4-binding globulin and albumin were markedly decreased in CRF and NTI; T4-binding prealbumin was increased in CRF and decreased in NTI. The mean concentration of nonesterified free fatty acids (FFA) in serum was increased in NTI but not in CRF. The weak, but significant, positive correlation observed between FT4 and FFA in serum (r = 0.34, P less than 0.01) in NTI indicates that the increase in serum FT4 in this group of patients could be an effect, at least in part, of FFA competing with T4 for binding sites on serum proteins. The stronger correlation detected between the serum FT4 concentration and the FFA/albumin molar ratio in serum (r = 0.60, P less than 0.001) demonstrates the importance of a low albumin concentration for expression of the effect of FFA on FT4 in severe systemic illnesses.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3111749

Source DB:  PubMed          Journal:  Clin Chem        ISSN: 0009-9147            Impact factor:   8.327


  5 in total

1.  Analytical and clinical evaluation of a new one-step non-analogue radioimmunoassay for serum-free thyroxine.

Authors:  R Sapin; F Gasser; J L Schlienger; J Chambron
Journal:  Eur J Nucl Med       Date:  1990

2.  Persistence of low serum thyroid hormone levels in a Graves' disease patient receiving supraphysiologic L-thyroxine replacement therapy.

Authors:  B N Premachandra; T W Burns; R Bregant; I K Williams; K D Burman
Journal:  J Endocrinol Invest       Date:  1989-12       Impact factor: 4.256

3.  Interferences in immunoassay.

Authors:  Jill Tate; Greg Ward
Journal:  Clin Biochem Rev       Date:  2004-05

4.  Analogous effects of serum lipids from patients with nonthyroidal illness and normal subjects on the uptake of thyroxine and its conversion to triiodothyronine by rat hepatocytes in culture.

Authors:  K Kluetsch; A Hotze; G S Rao
Journal:  Clin Investig       Date:  1993-01

5.  Thyroid hormone profile in peritransplant period in live donor kidney transplantation.

Authors:  P V Rao; K V Dakshinamurty; K S Saibaba; P V Murty; G Venkataramana; V Sreekrishna
Journal:  Indian J Clin Biochem       Date:  1999-07
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.